Trial Profile
A single centre trial evaluated the pharmacokinetics of imatinib mesylate in patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacokinetics
- 13 May 2016 New trial record